Search Results

Argentum Medical, a medical device leader and pioneer of silver-plated nylon technology, today announced the strategic combination with BioDerm, a leading provider of disposable medical devices, wound care products and Part B

The November layoffs are the second known workforce reduction this year for Marinus Pharmaceuticals, which previously announced disappointing Phase III results for ganaxolone in two clinical trials.

Today, Argentum, the leading national association serving senior living providers, has called for transparency in COVID-19 reporting among the states by releasing the following statement and call to action: ____________________ Openness and transparency are critical to maintaining the valued trust of senior living residents, fam

The headcount reduction will save money that the company will use in developing mavorixafor, its CXCR4 antagonist that last year received FDA approval to treat WHIM syndrome, in the larger patient population with chronic neutropenia.